Clinical Trial Update: Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of combining sofosbuvir with ribavirin in Japanese adults with chronic hepatitis C infection (genotype 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2015-03-24